Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies

BACKGROUND: To evaluate the impact of time to castration resistance (TTCR) in metastatic hormone-sensitive prostate cancer (mHSPC) patients on overall survival (OS) in the era of combination therapies for mHSPC. MATERIAL AND METHODS: Of 213 mHSPC patients diagnosed between 01/2013-12/2020 who subseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzel, Mike, Preisser, Felix, Hoeh, Benedikt, Schroeder, Maria, Würnschimmel, Christoph, Steuber, Thomas, Heinzer, Hans, Banek, Severine, Ahrens, Marit, Becker, Andreas, Karakiewicz, Pierre I., Chun, Felix K. H., Kluth, Luis A., Mandel, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103198/
https://www.ncbi.nlm.nih.gov/pubmed/33968764
http://dx.doi.org/10.3389/fonc.2021.659135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103198/
https://www.ncbi.nlm.nih.gov/pubmed/33968764
http://dx.doi.org/10.3389/fonc.2021.659135

Ejemplares similares